Activities

Filter
Oral presentation

Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL

Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)

21 Mar 2019

Activity: Talk or presentation typesOral presentation

Affections thromboemboliques veineuses – partie II

Jonathan Douxfils (Keynote speaker)

12 Mar 2019

Activity: Talk or presentation typesOral presentation

Spin-off et financement - Présentation de QUALIblood

Damien Gheldof (Speaker), & Jonathan Douxfils (Speaker)

6 Mar 2018

Activity: Talk or presentation typesOral presentation

DOACs: new test on development

Jonathan Douxfils (Speaker)

2 Mar 2018

Activity: Talk or presentation typesOral presentation

In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions

Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), , François Mullier (Speaker), & Jean-Michel Dogne (Speaker)

9 Feb 2018

Activity: Talk or presentation typesOral presentation

Nanoparticules dans les peintures: quels risques pour la santé?

Julie Laloy (Speaker)

2018

Activity: Talk or presentation typesOral presentation

Reduced point charge models of proteins - Influence of protein-solvent interactions

Laurence Leherte (Speaker)

28 Aug 2017

Activity: Talk or presentation typesOral presentation

Risk of vascular occlusive events with BCR-ABL TKIs in CML

Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)

25 Feb 2017

Activity: Talk or presentation typesOral presentation

Applications and prospects in multiresolution analyses of molecular structures and properties

Laurence Leherte (Speaker)

31 Jan 2017

Activity: Talk or presentation typesOral presentation

Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis

Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)

28 Apr 2016

Activity: Talk or presentation typesOral presentation

Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis

Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)

29 Jan 2016

Activity: Talk or presentation typesOral presentation

Risk of cardiovascular events associated with BCR-ABL TKI in leukemic population: a systematic review and meta-analysis

Jonathan Douxfils (Speaker), , Hélène Haguet (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)

Jun 2015

Activity: Talk or presentation typesOral presentation

Hemocompatibility of nanoparticles: impact on fibrinolysis.

Julie Laloy (Speaker)

2014

Activity: Talk or presentation typesOral presentation

Hemocompatibility of manufactured nanoparticles: Guidelines proposal.

Julie Laloy (Speaker)

2013

Activity: Talk or presentation typesOral presentation

Impact of nanomaterials on human health: Strategies of the Namur Nanosafety Center (NNC).

Julie Laloy (Speaker)

2012

Activity: Talk or presentation typesOral presentation

Assessment of different methods studying the impact of carbon nanomaterials on platelet function.

Julie Laloy (Speaker)

2012

Activity: Talk or presentation typesOral presentation